Published in Immunology on July 01, 2014
Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumors. J Immunol (2015) 0.82
Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice. Mol Neurobiol (2015) 0.81
Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid. J Cell Biochem (2015) 0.80
Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas. Oncoimmunology (2016) 0.79
Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design. J Clin Cell Immunol (2015) 0.76
Multiple Defects Impair the HLA Class II Antigen Presentation Capacity of Burkitt Lymphoma. J Clin Cell Immunol (2016) 0.75
Targeting Enolase in Reducing Secondary Damage in Acute Spinal Cord Injury in Rats. Neurochem Res (2017) 0.75
CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol (1994) 10.03
The c-Myc target gene network. Semin Cancer Biol (2006) 5.98
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer (2006) 2.77
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science (2003) 2.46
Burkitt's lymphoma. Lancet (2012) 2.02
A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis. Nat Med (1998) 1.96
Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem (2000) 1.80
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines. Proc Natl Acad Sci U S A (1987) 1.77
ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett (2000) 1.61
Identification of rat targets of anti-soluble liver antigen autoantibodies by serologic proteome analysis. Clin Chem (2003) 1.59
Biology and treatment of Burkitt's lymphoma. Curr Opin Hematol (2007) 1.45
Adult Burkitt lymphoma: advances in diagnosis and treatment. Oncology (Williston Park) (2008) 1.40
MYC and aggressive B-cell lymphomas. Adv Anat Pathol (2011) 1.38
HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol (2010) 1.38
Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J Exp Med (2002) 1.38
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J Immunol (1994) 1.37
Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J Virol (2005) 1.36
Burkitt lymphoma in adults. Hematology Am Soc Hematol Educ Program (2008) 1.35
Childhood Burkitt lymphoma: abdominal and pelvic imaging findings. AJR Am J Roentgenol (2009) 1.30
Antigen-specific CD4+ T-cell help is required to activate a memory CD8+ T cell to a fully functional tumor killer cell. Cancer Res (2002) 1.30
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer (2008) 1.30
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. J Proteomics (2011) 1.28
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proc Natl Acad Sci U S A (1992) 1.28
Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol (2012) 1.27
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci U S A (2003) 1.20
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma. Oncogene (1999) 1.15
Role of disulfide bonds in regulating antigen processing and epitope selection. J Immunol (2002) 1.14
Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood (2013) 1.13
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol Immunother (2008) 1.12
Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach. Hematol Oncol (2009) 1.09
Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion. J Immunol (2013) 1.09
Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J Clin Invest (1995) 1.09
Epstein-Barr virus: evasive maneuvers in the development of PTLD. Am J Transplant (2007) 1.08
CD8 T cell memory development: CD4 T cell help is appreciated. Immunol Res (2007) 1.06
Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol (1998) 1.05
Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc Natl Acad Sci U S A (1990) 1.03
Epstein-Barr virus and Burkitt lymphoma. Postgrad Med J (2008) 1.02
Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic (2000) 1.02
Epstein-barr virus and hodgkin lymphoma. Hematology Am Soc Hematol Educ Program (2007) 1.02
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. Int J Cancer (1996) 1.02
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells. Proc Natl Acad Sci U S A (2002) 1.01
Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing. Int Immunol (1997) 1.00
Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing. J Immunol (2003) 1.00
Role of APC in the selection of immunodominant T cell epitopes. J Immunol (1999) 1.00
Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition. J Immunol (2001) 0.97
Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease. Clin Chem (2008) 0.95
Defects in HLA class II antigen presentation in B-cell lymphomas. Leuk Lymphoma (2008) 0.95
HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition. Eur J Immunol (2008) 0.93
CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models. PLoS One (2013) 0.93
HLA class II antigen presentation by prostate cancer cells. Prostate Cancer Prostatic Dis (2007) 0.89
Burkitt lymphoma: the role of Epstein-Barr virus revisited. Br J Haematol (2012) 0.89
Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol. Leuk Lymphoma (2011) 0.89
Coordinate defects in human histocompatibility leukocyte antigen class II expression and antigen presentation in bare lymphocyte syndrome. J Exp Med (1994) 0.87
First crystal structure of an endo-inulinase, INU2, from Aspergillus ficuum: discovery of an extra-pocket in the catalytic domain responsible for its endo-activity. Biochimie (2012) 0.86
HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition. Clin Dev Immunol (2011) 0.85
Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells. Cell Immunol (2007) 0.83
t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia. Mol Cancer (2007) 0.83
Class II transactivator-induced expression of HLA-DO(beta) in HeLa cells. Tissue Antigens (2002) 0.83
Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia. Leuk Lymphoma (1999) 0.82
Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma. Br J Haematol (2006) 0.82
Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting. Pediatr Blood Cancer (2012) 0.80
Presentation of abundant endogenous class II DR-restricted antigens by DM-negative B cell lines. Eur J Immunol (1997) 0.80
Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease. Int J Hematol (2003) 0.79
Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells. Cancer Res (1991) 0.78
Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia. Leuk Res (2008) 0.76
Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med (2009) 3.46
Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res (2011) 2.08
Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J Am Soc Nephrol (2008) 1.56
Determinants of the incidence of hand, foot and mouth disease in China using geographically weighted regression models. PLoS One (2012) 1.52
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. J Neurochem (2014) 1.47
Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera. Gastroenterology (2007) 1.42
Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin Cancer Res (2005) 1.40
Improving the performance of outbreak detection algorithms by classifying the levels of disease incidence. PLoS One (2013) 1.36
The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin Sci (Lond) (2011) 1.34
Impaired enterocyte proliferation in aquaporin-3 deficiency in mouse models of colitis. Gut (2007) 1.33
Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin Cancer Res (2008) 1.31
Near-infrared photocatalysis based on YF3 : Yb3+,Tm3+/TiO2 core/shell nanoparticles. Chem Commun (Camb) (2010) 1.31
Associations of functional polymorphisms in cyclooxygenase-2 and platelet 12-lipoxygenase with risk of occurrence and advanced disease status of colorectal cancer. Carcinogenesis (2006) 1.28
Phenotype analysis of aquaporin-8 null mice. Am J Physiol Cell Physiol (2005) 1.23
Spatiotemporal analysis of indigenous and imported dengue fever cases in Guangdong province, China. BMC Infect Dis (2012) 1.21
Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion. Am J Physiol Renal Physiol (2006) 1.20
FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med (2005) 1.19
Scheelite-type NaEr(MoO(4))(2). Acta Crystallogr Sect E Struct Rep Online (2010) 1.17
Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis (2006) 1.16
Haplotypes in matrix metalloproteinase gene cluster on chromosome 11q22 contribute to the risk of lung cancer development and progression. Clin Cancer Res (2006) 1.16
Evidence against functionally significant aquaporin expression in mitochondria. J Biol Chem (2006) 1.15
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol Immunother (2008) 1.12
Mechanosensitive properties in the endothelium and their roles in the regulation of endothelial function. J Cardiovasc Pharmacol (2013) 1.11
Highly stable porous polymer networks with exceptionally high gas-uptake capacities. Adv Mater (2011) 1.10
Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides. Chem Biol (2008) 1.09
Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. J Immunol (2004) 1.09
Synthesis, structure, properties, and application of a carbazole-based diaza[7]helicene in a deep-blue-emitting OLED. Chemistry (2012) 1.04
Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer. Carcinogenesis (2007) 1.03
Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol (2007) 1.01
A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. Int J Biochem Cell Biol (2012) 1.00
An isoreticular series of metal-organic frameworks with dendritic hexacarboxylate ligands and exceptionally high gas-uptake capacity. Angew Chem Int Ed Engl (2010) 0.99
Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome. Cardiovasc Res (2012) 0.98
Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis. Clin Cancer Res (2008) 0.98
Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation. J Biol Chem (2012) 0.97
MicroRNAs 144, 145, and 214 are down-regulated in primary neurons responding to sciatic nerve transection. Brain Res (2011) 0.97
Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol (2010) 0.96
Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. Int J Cancer (2012) 0.96
Burkitt lymphoma: pathogenesis and immune evasion. J Oncol (2010) 0.96
Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. Am J Physiol Lung Cell Mol Physiol (2008) 0.95
17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. J Steroid Biochem Mol Biol (2006) 0.95
Defects in HLA class II antigen presentation in B-cell lymphomas. Leuk Lymphoma (2008) 0.95
Anti-inflammation effects of Cordyceps sinensis mycelium in focal cerebral ischemic injury rats. Inflammation (2011) 0.94
Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation. Oncol Rep (2011) 0.94
Dynamic epigenetic changes involved in testicular toxicity induced by di-2-(ethylhexyl) phthalate in mice. Basic Clin Pharmacol Toxicol (2009) 0.94
Mild hypoxia-induced cardiomyocyte hypertrophy via up-regulation of HIF-1α-mediated TRPC signalling. J Cell Mol Med (2012) 0.93
Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer. J Med Genet (2010) 0.93
HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition. Eur J Immunol (2008) 0.93
Double potential interval and transisthmus conduction time for prediction of cavotricuspid isthmus block after ablation of typical atrial flutter. J Interv Card Electrophysiol (2002) 0.92
Hsp90 inhibitor partially corrects nephrogenic diabetes insipidus in a conditional knock-in mouse model of aquaporin-2 mutation. FASEB J (2008) 0.92
Normal shear stress and vascular smooth muscle cells modulate migration of endothelial cells through histone deacetylase 6 activation and tubulin acetylation. Ann Biomed Eng (2010) 0.92
Abnormal expression of PER1 circadian-clock gene in oral squamous cell carcinoma. Onco Targets Ther (2012) 0.92
Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma. Cancer Res (2009) 0.92
Sulfonate-grafted porous polymer networks for preferential CO2 adsorption at low pressure. J Am Chem Soc (2011) 0.91
Lithium samarium polyphosphate, LiSm(PO(3))(4). Acta Crystallogr Sect E Struct Rep Online (2010) 0.91
Temporal trends and spatial variation characteristics of hazardous air pollutant emission inventory from municipal solid waste incineration in China. Environ Sci Technol (2012) 0.91
Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms. Pharmacogenet Genomics (2007) 0.89
Change of adsorption modes of dyes on fluorinated TiO2 and its effect on photocatalytic degradation of dyes under visible irradiation. Langmuir (2008) 0.89
Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate. J Neuroimmunol (2010) 0.89
Reduced urea flux across the blood-testis barrier and early maturation in the male reproductive system in UT-B-null mice. Am J Physiol Cell Physiol (2007) 0.89
Highly plasmon-enhanced upconversion emissions from Au@β-NaYF4:Yb,Tm hybrid nanostructures. Chem Commun (Camb) (2011) 0.89
Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol. Leuk Lymphoma (2011) 0.89
Block-copolymer-mediated nanoparticle dispersion and assembly in polymer nanocomposites. Adv Mater (2014) 0.89
Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. J Neuroimmunol (2010) 0.88
Bioactive metabolites from Chaetomium globosum L18, an endophytic fungus in the medicinal plant Curcuma wenyujin. Phytomedicine (2011) 0.88
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci (2016) 0.88
The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells. PLoS One (2013) 0.88
Role of the epithelial sodium channel in salt-sensitive hypertension. Acta Pharmacol Sin (2011) 0.88
Microbial community structures in mixed bacterial consortia for azo dye treatment under aerobic and anaerobic conditions. J Hazard Mater (2012) 0.88
Maslinic acid induces apoptosis in salivary gland adenoid cystic carcinoma cells by Ca2+-evoked p38 signaling pathway. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.88
Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome. Am J Med Genet A (2012) 0.87
Protective effect of extract of Cordyceps sinensis in middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Behav Brain Funct (2010) 0.87
Follicle stimulating hormone receptor G-29A, 919A>G, 2039A>G polymorphism and the risk of male infertility: a meta-analysis. Gene (2012) 0.87
Reversibility of anodic lithium in rechargeable lithium-oxygen batteries. Nat Commun (2013) 0.87
Dietary conjugated linoleic acid increases PPAR gamma gene expression in adipose tissue of obese rat, and improves insulin resistance. Growth Horm IGF Res (2008) 0.87
Enhanced immune response and protective effects of nano-chitosan-based DNA vaccine encoding T cell epitopes of Esat-6 and FL against Mycobacterium tuberculosis infection. PLoS One (2013) 0.87
Decreased saliva secretion and down-regulation of AQP5 in submandibular gland in irradiated rats. Radiat Res (2006) 0.87
Combinatorial synthesis of thrombin-binding aptamers containing iso-guanine. J Comb Chem (2009) 0.87
Aberrant expression of clock gene period1 and its correlations with the growth, proliferation and metastasis of buccal squamous cell carcinoma. PLoS One (2013) 0.87
Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis. Acta Diabetol (2009) 0.87
Cyclic strain modulates migration and proliferation of vascular smooth muscle cells via Rho-GDIalpha, Rac1, and p38 pathway. J Cell Biochem (2010) 0.87
Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3. Asian Pac J Cancer Prev (2011) 0.87
Evidence from knockout mice against physiologically significant aquaporin 8-facilitated ammonia transport. Am J Physiol Cell Physiol (2006) 0.86
Hydrogen sulfide prevents hydrogen peroxide-induced activation of epithelial sodium channel through a PTEN/PI(3,4,5)P3 dependent pathway. PLoS One (2013) 0.86
Quantum dot-mediated photoproduction of reactive oxygen species for cancer cell annihilation. Photochem Photobiol (2009) 0.86
MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma. Mol Carcinog (2012) 0.86
TiO₂ photoanode structure with gradations in V concentration for dye-sensitized solar cells. ACS Appl Mater Interfaces (2011) 0.86
Lentivirus-mediated RNA interference targeting the H19 gene inhibits cell proliferation and apoptosis in human choriocarcinoma cell line JAR. BMC Cell Biol (2013) 0.86
Site-specific microtubule-associated protein 4 dephosphorylation causes microtubule network densification in pressure overload cardiac hypertrophy. J Biol Chem (2010) 0.86
Apoptosis of glomerular mesangial cells induced by sublytic C5b-9 complexes in rats with Thy-1 nephritis is dependent on Gadd45 gamma upregulation. Eur J Immunol (2009) 0.85
HLA class II defects in Burkitt lymphoma: bryostatin-1-induced 17 kDa protein restores CD4+ T-cell recognition. Clin Dev Immunol (2011) 0.85
Bright white upconversion emission from Yb(3+), Er(3+), and Tm(3+)-codoped Gd(2)O(3) nanotubes. Phys Chem Chem Phys (2010) 0.85
Association of the variable number of tandem repeats polymorphism in the promoter region of the SMYD3 gene with risk of esophageal squamous cell carcinoma in relation to tobacco smoking. Cancer Sci (2008) 0.85
Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-L-cysteine capped quantum dots. Biomaterials (2009) 0.85
Vitamin A deficiency aggravates iron deficiency by upregulating the expression of iron regulatory protein-2. Nutrition (2011) 0.85